XML 50 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies Segment Information and Signficant Customers (Details) - segment
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Accounting Policies [Abstract]      
Number of operating segments 1    
Entity Wide Revenue Sanofi Percentage   89.00% 53.00%
LXRX Diplomat customer concentration 22.00%   14.00%
Biologics customer concentration 65.00%   25.00%